Alumis Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Alumis Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares GlobeNewswire January 09, 2026 SOUTH SAN FRANCISCO, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced the closing of its upsized […]

Aon Announces Quarterly Cash Dividend

Aon plc (NYSE: AON), a leading global professional services firm, today announced that the Board of Directors has declared a quarterly cash dividend of $0.745 per share on Aon’s outstanding Class A Ordinary Shares. The dividend is payable February 13, 2026 to shareholders of record on February 2, 2026. About Aon Aon plc (NYSE: AON)

Early Warning Filing by The Edna Gareh Spousal Trust

(TSX:SEC), NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES AND NOT FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Jan. 09, 2026 (GLOBE NEWSWIRE) — The Edna Gareh Spousal Trust (the “Trust”) announces the filing of an early warning report (the “Report”) in connection with its indirect holdings (through Revroy Enterprises Ltd. (“Revroy”), a corporation controlled

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:PRAX), BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that on January 2, 2026, the Compensation Committee of Praxis' Board of Directors granted restricted stock

JYD DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Jayud Global Logistics Ltd. Investors to Secure Counsel Before Important January 20 Deadline in Securities Class Action – JYD

(NASDAQ:JYD), NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jayud Global Logistics Ltd. (NASDAQ: JYD) between April 21, 2023 and April 30, 2025, both dates inclusive (the “Class Period”), of the important January 20, 2026 lead plaintiff deadline. SO WHAT:

Early Warning Filing by The Edna Gareh Spousal Trust

Early Warning Filing by The Edna Gareh Spousal Trust GlobeNewswire January 09, 2026 NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES AND NOT FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Jan. 09, 2026 (GLOBE NEWSWIRE) — The Edna Gareh Spousal Trust (the “Trust”) announces the filing of an early warning report (the “Report”) in connection

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire January 09, 2026 BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that

NANO Nuclear to Participate in and Present at Needham’s 28th Annual Growth Conference

(NASDAQ:NNE), New York, N.Y., Jan. 09, 2026 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor and technology company focused on developing clean energy solutions, today announced its participation in Needham's 28th Annual Growth Conference on Tuesday, January 13, 2026 at the Lotte

Scroll to Top